Aripiprazole
Aripiprazole Orion contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics.
It is used to treat adults and adolescents aged 15 years and older with schizophrenia, a mental illness with symptoms such as hearing, seeing, or feeling things that are not there, suspiciousness, mistaken beliefs, disorganized thinking and behavior, and emotional flatness. Patients with these symptoms may also feel depressed, anxious, or tense.
Aripiprazole Orion is also used to treat moderate to severe manic episodes in adults and in adolescents aged 13 years and older with bipolar I disorder, a mental illness with symptoms such as high mood, feeling full of energy, reduced need for sleep, and impaired attention.
Before taking Aripiprazole Orion, tell your doctor:
Suicidal thoughts and behaviors have been reported during aripiprazole treatment. Tell your doctor immediately if you have thoughts of harming or killing yourself at any time.
Before taking Aripiprazole Orion, tell your doctor if you have:
If you notice any of the following side effects after taking Aripiprazole Orion, tell your doctor:
weight gain, unusual movements, drowsiness that interferes with daily activities, difficulty swallowing, or signs of allergy.
If you are an elderly patient with dementia, or if you are caring for someone with dementia, you should tell the doctor if the patient has ever had a stroke or a "mini" stroke.
Tell your doctor immediately if you have:
muscle stiffness or stiffness with high fever, sweating, altered mental status, or very rapid or irregular heartbeat.
If you or your family/caregiver notice that you are developing impulses, urges, or behaviors that you cannot control, such as an overwhelming urge to gamble, increased sexual urges, or excessive spending, tell your doctor.
These impulses are known as impulse control disorders and can be intense and difficult to control. Your doctor may need to adjust your dose or stop your treatment.
Aripiprazole may cause drowsiness, dizziness, and changes in your ability to move and balance, which may increase the risk of falls. Be careful, especially if you are elderly or frail.
Do not take Aripiprazole Orion if you are under 13 years of age. It is not known if the medicine is safe and effective in children under 13 years of age.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, including those obtained without a prescription.
Medicines that lower blood pressure: Aripiprazole Orion may increase the effect of medicines that lower blood pressure. If you are taking medicines that lower blood pressure, tell your doctor.
Taking Aripiprazole Orion with other medicines may require a change in the dose of Aripiprazole Orion or other medicines you are taking. It is especially important to tell your doctor if you are taking:
Taking these medicines with Aripiprazole Orion may increase the risk of side effects or reduce the effectiveness of Aripiprazole Orion. If you experience any unusual symptoms while taking these medicines with Aripiprazole Orion, tell your doctor.
Medicines that increase serotonin levels are usually used to treat depression, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, and social anxiety disorder, as well as migraine and pain:
These medicines may increase the risk of side effects. If you experience any unusual symptoms while taking these medicines with Aripiprazole Orion, tell your doctor.
This medicine can be taken with or without food.
Do not drink alcohol while taking Aripiprazole Orion.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
In newborns whose mothers took Aripiprazole Orion during the last trimester (last three months of pregnancy), the following symptoms have been reported: trembling, stiffness, and (or) weakness, sleepiness, agitation, difficulty breathing, and difficulty feeding. If you notice any of these symptoms in your baby, contact your doctor.
If you are taking Aripiprazole Orion and are pregnant or planning to become pregnant, your doctor will discuss with you whether you should continue to take Aripiprazole Orion. You should not take Aripiprazole Orion and breastfeed at the same time. You should talk to your doctor about the best way to feed your baby if you are taking Aripiprazole Orion.
Aripiprazole Orion may cause dizziness, drowsiness, and vision problems (see section 4). This should be taken into account when performing activities that require full attention, such as driving a car or operating machinery.
Aripiprazole Orion contains lactose (in the form of lactose monohydrate): 5 mg tablets contain 72.2 mg, 10 mg tablets contain 63.2 mg, 15 mg tablets contain 94.8 mg, and 30 mg tablets contain 189.5 mg of lactose.
Patients with intolerance to some sugars should contact their doctor before taking Aripiprazole Orion.
Take this medicine exactly as your doctor or pharmacist has told you. If you are not sure, ask your doctor or pharmacist.
The recommended dose of Aripiprazole Orion for adults is 15 mg once a day. Your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
Treatment with aripiprazole may be started at a low dose, given as a liquid solution. The dose may be gradually increased to the recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe a lower or higher dose, up to a maximum of 30 mg once a day.
If you feel that the effect of Aripiprazole Orion is too strong or too weak, talk to your doctor or pharmacist.
Aripiprazole Orion tablets should be taken once a day at the same time. It does not matter whether you take it with or without food. Swallow the tablet whole with water.
Even if you feel better, do not change your dose or stop taking Aripiprazole Orion without talking to your doctor first.
If you have taken more Aripiprazole Orion than your doctor prescribed, contact your doctor or the nearest hospital immediately. If you cannot contact your doctor, go to the nearest hospital and take the packaging of the medicine with you.
Patients who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
If you experience any of these symptoms, contact your doctor or hospital immediately.
If you miss a dose, take it as soon as you remember. Do not take a double dose on the same day.
Do not stop taking Aripiprazole Orion unless your doctor tells you to. It is very important to continue taking Aripiprazole Orion for as long as your doctor tells you to.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
The following side effects have been reported during post-marketing use of aripiprazole, but the frequency of these side effects is not known (cannot be estimated from the available data):
If you experience any of these behaviors, tell your doctor, who will discuss ways to manage or reduce these symptoms with you.
In elderly patients with dementia treated with aripiprazole, there have been more reports of death. Additionally, there have been reports of stroke or "mini" stroke.
In adolescents aged 13 years and older, side effects have been reported with a similar frequency and type as in adults, except for drowsiness, uncontrolled movements or sudden movements, restlessness, and fatigue, which have been reported very commonly (may affect more than 1 in 10 people), as well as upper abdominal pain, dry mouth, rapid heartbeat, weight gain, increased appetite, tremors, uncontrolled movements of the limbs, and dizziness, especially when standing up from a lying or sitting position, which have been reported commonly (may affect up to 1 in 10 people).
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
Side effects can be reported to the national reporting system listed below.
You can also report side effects directly via the national reporting system:
Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Jerozolimskie Avenue 181C, 02-222 Warsaw, phone: 22 49 21 301, fax: 22 49 21 309,
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the blister or carton after EXP. The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
Aripiprazole Orion 5 mg tablets are blue, modified rectangular, uncoated, and marked with the number "62" on one side and the letter "H" on the other side.
Aripiprazole Orion 10 mg tablets are white, modified rectangular, uncoated, and marked with the number "63" on one side and the letter "H" on the other side.
Aripiprazole Orion 15 mg tablets are white, round, uncoated, and marked with the number "64" on one side and the letter "H" on the other side.
Aripiprazole Orion 30 mg tablets are white, round, uncoated, and marked with the number "66" on one side and the letter "H" on the other side.
Aripiprazole Orion tablets are available in blisters (PA/Aluminum/PVC/Aluminum), packaged in cardboard boxes containing 14, 28, 56, or 98 tablets, or in HDPE bottles with PP caps, packaged in cardboard boxes containing 100 or 200 tablets.
The bottle contains a desiccant.
Not all pack sizes may be marketed.
Orion Corporation
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation, Orion Pharma
Orionintie 1
FI-02200 Espoo
Finland
Orion Corporation, Orion Pharma
Joensuunkatu 7
FI-24100 Salo
Finland
To obtain more detailed information on this medicine, contact the local representative of the marketing authorization holder:
Orion Pharma Poland Sp. z o.o.
contact@orionpharma.info.pl
Date of last revision of the leaflet:14.10.2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.